Sky Century Investment (SKYI) Net Cash Flow Growth (1y) (2013 - 2026)
Sky Century Investment (SKYI) Net Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -117.27% |
| 3 | Zoetis | 31.45 Bn | 29.77 Bn | 1.05 Bn | -167.84% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -290.21% |
| 5 | United Therapeutics | 22.23 Bn | 19.57 Bn | 683.80 Mn | 270.63% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -367.42% |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn | -7.60% |
| 8 | Elanco Animal Health | 11.70 Bn | 11.17 Bn | 798.00 Mn | 272.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Sky Century Investment | 393,547.71 | 393,283.71 | 26,045.00 | -127.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -127.37% |
| Feb 28, 2014 | -2,425.00% |
| Nov 30, 2013 | 1,117.20% |
| Aug 31, 2013 | 107.84% |